Overview

Amerge was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute migraine headaches with or without aura in adults. Amerge was also known by its drug name, naratriptan. 

Amerge was a triptan. Triptans are believed to work by constricting blood vessels and reducing inflammation.
How was it taken?

Amerge was generally taken once or twice a day. Amerge came in tablet form.

Side effects

The FDA-approved label for Amerge listed common side effects including dizziness, drowsiness, malaise, fatigue, “pins and needles” tingling sensation, nausea, and throat and neck discomfort. 

Rare but serious side effects listed for Amerge included stroke, cerebral hemorrhage (bleeding), serotonin syndrome, medication overuse headache, sensation of tightness, heaviness, or pressure in the chest, throat, jaw, neck, or other body parts, and ischemia (insufficient blood supply) to the heart, spleen, or gastrointestinal system.

For more details about this treatment, visit:

Amerge — Drugs.com